中等度〜重度の虚血を認める安定虚血性心疾患を有する進行性慢性腎臓病（CKD）患者において、初期の侵襲的治療戦略（血管造影＋血行再建術＋ガイドラインに基づく薬物療法）は、保存的治療戦略（ガイドラインに基づく薬物療法）と比較し、狭心症関連 ...

中等度以上の虚血が認められる安定虚血性心疾患の患者に対し、経皮的冠動脈インターベンション（PCI）または冠動脈バイパス術（CABG）などの侵襲的治療は、至適薬物治療による非侵襲的治療に比べ、狭心症関連の健康状態アウトカムが良好であることが ...

Medically reviewed by Christopher Lee, MD Key Takeaways Ischemia is when there is a blockage of blood flow to a part of the ...

Sir, you are no longer a maverick. We should have listened to you. It took over 40 years, but today, at the American Heart Association (AHA) Scientific Sessions 2019, we learned that you were right to ...

中等度以上の虚血がある慢性冠動脈疾患患者で早期の侵襲的治療と保存的治療を比較したISCHEMIA試験の参加者の死亡率を追跡調査で検討。ISCHEMIA試験では、参加者を侵襲的治療（INV）群と保存的治療（CON）群に無作為化した。今回、2021年12月までに得られた ...

The relationship between the extent and severity of stress-induced ischemia and the extent and severity of anatomic coronary artery disease (CAD) in patients with obstructive CAD is multifactorial and ...

CorVista Health, a leader in noninvasive cardiovascular diagnostics, today announced new data evaluating a physiologic signal–based machine-learning model for detecting cardiac ischemia. The data was ...

The innate immune response is the body's first line of defense against external pathogens and endogenous damage signals. The cGAS-STING pathway is a crucial component of the innate immune response, ...

PHILADELPHIA, PA (UPDATED)—After more than 10 years and $100 million, the International Study of Comparative Health Effectiveness With Medical And Invasive Approaches (ISCHEMIA) has delivered a ...

Critical Limb Ischemia Market Outlook 2025-2035: The 7 major critical limb ischemia market reached a value of USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 2.5 ...